Medline Inc (NASDAQ:MDLN) reported mixed results for the fourth quarter on Wednesday.
The company posted a quarterly loss of 1 cent per share which missed the analyst consensus estimate of earnings of 18 cents per share. The company reported quarterly sales of $7.787 billion which beat the analyst consensus estimate of $7.547 billion.
“We delivered strong fourth quarter results, concluding a successful 2025 with $2.4 billion in total new customer signings,” said Jim Boyle, Chief Executive Officer of Medline. “This performance reflects the confidence customers place in our value, …